Literature DB >> 24495792

Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis.

Zhendong Liu1, Yingxin Zhao2, Fang Wei3, Lin Ye4, Fanghong Lu2, Hua Zhang2, Yutao Diao2, Hongbin Song2, Zaiwen Qi2.   

Abstract

OBJECTIVES: To explore synergistic effect between angiotensin II receptor blockers (ARBs) and statins on Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis.
METHODS: This study was a 2 × 2 factorial randomized, prospective, double-blind, placebo-controlled trial. One hundred and fifty nine hypertensive patients with carotid atherosclerosis were randomized to the administration of control group, telmisartan group, rosuvastatin group, and combination group (telmisartan plus rosuvastatin) base on hydrochlorothiazide treatment. Carotid ultrasonography, parameters of Th17/Treg functional axis, interleukin (IL)-1β, IL-2, interferon (IFN)-γ, hypersensitive C-reactive protein (hsCRP), monocyte chemotactic protein (MCP)-1 were evaluated.
RESULTS: Blood pressure level markedly reduced in four groups. There was significantly synergistic effect of combination of telmisartan with rosuvastatin on reducing carotid imtima-media thickness (IMT), Th17 cells frequency, IL-17, IL-6, IL-23, tumor necrosis factor (TNF)-α, expression of retinoic acid receptor-related orphan receptor (ROR)γt mRNA, Th17/Treg ratio, IL-1β, IL-2, IFN-γ, hsCRP, and MCP-1, and increasing Treg cells frequency, IL-10, transforming growth factor(TGF)-β1, and expression of forkhead/winged helix transcription factor (Foxp3) mRNA (all P<0.05). Change rate of IMT statistical positively related to descent rates of Th17 cells frequency, IL-17, IL-6, IL-23, TNF-α, expression of RORγt mRNA, Th17/Treg ratio, IL-1β, IL-2, IFN-γ, hsCRP, and MCP-1, and negatively related to increased rates of Treg frequency, IL-10, TGF-β1, and expression of Foxp3 mRNA, respectively (all P<0.05).
CONCLUSION: There is a synergistic effect of combination of telmisartan with rosuvastatin on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Angiotensin II receptor blockers; Anti-inflammation; Atherosclerosis; Hypertension; Statin; Synergistic effect

Mesh:

Substances:

Year:  2014        PMID: 24495792     DOI: 10.1016/j.atherosclerosis.2013.12.004

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  20 in total

1.  Abnormal CD161+ immune cells and retinoic acid receptor-related orphan receptor γt-mediate enhanced IL-17F expression in the setting of genetic hypertension.

Authors:  Madhu V Singh; Michael Z Cicha; Santosh Kumar; David K Meyerholz; Kaikobad Irani; Mark W Chapleau; François M Abboud
Journal:  J Allergy Clin Immunol       Date:  2017-01-16       Impact factor: 10.793

Review 2.  Sex differences in T cells in hypertension.

Authors:  Ashlee J Tipton; Jennifer C Sullivan
Journal:  Clin Ther       Date:  2014-08-16       Impact factor: 3.393

3.  Telmisartan increases systemic exposure to rosuvastatin after single and multiple doses, and in vitro studies show telmisartan inhibits ABCG2-mediated transport of rosuvastatin.

Authors:  Miao Hu; Hon-Kit Lee; Kenneth K W To; Benny S P Fok; Siu-Kwan Wo; Chung-Shun Ho; Chun-Kwok Wong; Zhong Zuo; Thomas Y K Chan; Juliana C N Chan; Brian Tomlinson
Journal:  Eur J Clin Pharmacol       Date:  2016-09-20       Impact factor: 2.953

Review 4.  T-cell involvement in sex differences in blood pressure control.

Authors:  G Ryan Crislip; Jennifer C Sullivan
Journal:  Clin Sci (Lond)       Date:  2016-05-01       Impact factor: 6.124

Review 5.  Regulatory T cells in cardiovascular diseases.

Authors:  Xiao Meng; Jianmin Yang; Mei Dong; Kai Zhang; Eric Tu; Qi Gao; Wanjun Chen; Cheng Zhang; Yun Zhang
Journal:  Nat Rev Cardiol       Date:  2015-11-03       Impact factor: 32.419

Review 6.  Role of Inflammation and Immunity in Hypertension: Recent Epidemiological, Laboratory, and Clinical Evidence.

Authors:  Antoine Caillon; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

7.  Hypertension-induced subclinical vascular and cognitive changes are reversible-An observational cohort study.

Authors:  Katalin Réka Czuriga-Kovács; Csilla Cecília Szekeres; Zoltán Bajkó; Krisztina Csapó; László Oláh; Mária Tünde Magyar; Sándor Molnár; Dániel Czuriga; László Kardos; Andrea Bojtor Burainé; Dániel Bereczki; Pál Soltész; László Csiba
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-04-13       Impact factor: 3.738

8.  CCR5 facilitates endothelial progenitor cell recruitment and promotes the stabilization of atherosclerotic plaques in ApoE-/- mice.

Authors:  Zhongwen Zhang; Jianjun Dong; Corrinne G Lobe; Peiyun Gong; Ju Liu; Lin Liao
Journal:  Stem Cell Res Ther       Date:  2015-03-19       Impact factor: 6.832

Review 9.  Th17 cells in autoimmune and infectious diseases.

Authors:  José Francisco Zambrano-Zaragoza; Enrique Jhonatan Romo-Martínez; Ma de Jesús Durán-Avelar; Noemí García-Magallanes; Norberto Vibanco-Pérez
Journal:  Int J Inflam       Date:  2014-08-03

Review 10.  The Redox-Metabolic Couple of T Lymphocytes: Potential Consequences for Hypertension.

Authors:  Cassandra M Moshfegh; Adam J Case
Journal:  Antioxid Redox Signal       Date:  2020-04-30       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.